Shannon John Patrick Jr - Net Worth and Insider Trading
Shannon John Patrick Jr Net Worth
The estimated net worth of Shannon John Patrick Jr is at least $3 Million dollars as of 2024-05-04. Shannon John Patrick Jr is the See Remarks of Xeris Biopharma Holdings Inc and owns about 1,408,575 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $3 Million. Details can be seen in Shannon John Patrick Jr's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Shannon John Patrick Jr has not made any transactions after 2023-11-17 and currently still holds the listed stock(s).
Transaction Summary of Shannon John Patrick Jr
Shannon John Patrick Jr Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shannon John Patrick Jr owns 1 companies in total, including Xeris Biopharma Holdings Inc (XERS) .
Click here to see the complete history of Shannon John Patrick Jr’s form 4 insider trades.
Insider Ownership Summary of Shannon John Patrick Jr
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2023-11-17 | See Remarks |
Shannon John Patrick Jr Latest Holdings Summary
Shannon John Patrick Jr currently owns a total of 1 stock. Shannon John Patrick Jr owns 1,408,575 shares of Xeris Biopharma Holdings Inc (XERS) as of November 17, 2023, with a value of $3 Million.
Latest Holdings of Shannon John Patrick Jr
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2023-11-17 | 1,408,575 | 1.89 | 2,662,207 |
Holding Weightings of Shannon John Patrick Jr
Shannon John Patrick Jr Form 4 Trading Tracker
According to the SEC Form 4 filings, Shannon John Patrick Jr has made a total of 5 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 30,769 shares on November 17, 2023, which cost Shannon John Patrick Jr around $50,461.
Insider Trading History of Shannon John Patrick Jr
- 1
Shannon John Patrick Jr Trading Performance
GuruFocus tracks the stock performance after each of Shannon John Patrick Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shannon John Patrick Jr is 18.83%. GuruFocus also compares Shannon John Patrick Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shannon John Patrick Jr within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Shannon John Patrick Jr's insider trading performs compared to the benchmark.
Performance of Shannon John Patrick Jr
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.01 | | | | | |
| Relative Return to S&P 500(%) | 11.3 | | | | | |
Shannon John Patrick Jr Ownership Network
Shannon John Patrick Jr Owned Company Details
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Shannon John Patrick Jr is the See Remarks of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , director & See Remarks Paul R Edick , and Chief Scientific Officer Steven Prestrelski .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Shannon John Patrick Jr made 1 insider transaction in Xeris Biopharma Holdings Inc (XERS) with a net purchase of 30,769. Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 30,000 shares made by Paul R Edick , a net purchase of 11,000 shares made by John P. Schmid , and a net purchase of 28,000 shares made by Steven Pieper .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 4,500 shares, with a net purchase of 4,500 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 110,579 shares were bought by its insiders, resulting in a net purchase of 110,579 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
Shannon John Patrick Jr Mailing Address
Above is the net worth, insider trading, and ownership report for Shannon John Patrick Jr. You might contact Shannon John Patrick Jr via mailing address: Durata Therapeutics, Inc., 89 Headquarters Plaza North, 14th Floor, Morristown Nj 07960.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
